Inventor
FARINA CARLO
IT36 patents
⚠️ This page may combine multiple inventors who share the name “FARINA CARLO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISF SPA
13 patentsUS4530934AJul 23, 1985
Pharmaceutically active ursolic acid derivative
ISF SPA7 citations73
US5130319AJul 14, 1992
Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines
ISF SPA7 citations72
US5053422AOct 1, 1991
Psychotropic perhydroazacycloalka [1,2-A] imidazole derivatives
ISF SPA11 citations72
US4868313ASep 19, 1989
A process for making pyrrolidone derivatives
ISF SPA8 citations72
US4824861AApr 25, 1989
Pyrrolidone derivatives and memory enhancement use thereof
ISF SPA6 citations72
US4173648ANov 6, 1979
3β-Hydroxy-18β-olean-9-en-30-oic acids
ISF SPA12 citations68
US4632982ADec 30, 1986
Triphenylmethyl azo and hydrazino substituted pyridazines
ISF SPA1 citations63
US4575552AMar 11, 1986
Process of making ethyl[6-[ethyl-(2-hydroxypropyl)amino]-3-pyridazinyl]hydrazine carboxylate
ISF SPA4 citations63
US5200406AApr 6, 1993
Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
ISF SPA5 citations61
US4719222AJan 12, 1988
Pharmacologically active 5-oxo-1-imidazolidine acetamide compounds
ISF SPA3 citations61
US4703054AOct 27, 1987
Nootropic imidazolidinones
ISF SPA1 citations51
US5082939AJan 21, 1992
Pyridazine derivatives
ISF SPA1 citations50
US4873328AOct 10, 1989
Process for preparing alkoxyalkylidenehydrazinopyridazine derivatives
ISF SPA1 citations50
SMITHKLINE BEECHAM SPA
7 patentsUS6277862B1Aug 21, 2001
Quinoline derivatives
SMITHKLINE BEECHAM SPA47 citations91
US6743804B2Jun 1, 2004
Quinoline derivatives as NK3 antagonists
SMITHKLINE BEECHAM SPA11 citations72
US6355654B1Mar 12, 2002
Salts of quinoline derivatives as NK3 antagonists
SMITHKLINE BEECHAM SPA11 citations72
US6025390AFeb 15, 2000
Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption
SMITHKLINE BEECHAM SPA15 citations71
US6432977B1Aug 13, 2002
Salts of quinoline derivatives as NK3 antagonists
SMITHKLINE BEECHAM SPA8 citations69
US6613770B1Sep 2, 2003
Quinoline derivatives as NK-2 and NK-3 receptor ligands
SMITHKLINE BEECHAM SPA5 citations61
US6780875B2Aug 24, 2004
Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
SMITHKLINE BEECHAM SPA6 citations60
NEUROTUNE AG
4 patentsUS7544705B2Jun 9, 2009
Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
NEUROTUNE AG18 citations89
US7732473B2Jun 8, 2010
Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
NEUROTUNE AG3 citations59
US7989421B2Aug 2, 2011
Use of dimiracetam in the treatment of chronic pain
NEUROTUNE AG0 citations47
US7973066B2Jul 5, 2011
Pyrrolo[1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
NEUROTUNE AG1 citations47
SMITHKLINE BEECHAM FARMA
3 patentsNIKEM RESEARCH SRL
3 patentsUS6787550B1Sep 7, 2004
Indole derivatives and their use for the treatment of osteoporosis amongst other applications
NIKEM RESEARCH SRL14 citations78
US6903117B2Jun 7, 2005
Indole derivatives for the treatment of osteoporosis
NIKEM RESEARCH SRL6 citations60
US7220769B2May 22, 2007
Azolylbenzamides and analogues and their use for treating osteoporosis
NIKEM RESEARCH SRL6 citations58